References
- Yadav K, Singh D. Protein biomarker for psoriasis: a systematic review on their role in the pathomechanism, diagnosis, potential targets and treatment of psoriasis. Int J Biol Macromol. 2018;118:1796–1810. doi:10.1016/j.ijbiomac.2018.07.021.
- Murdaca G, Gulli R, Spanò F, et al. TNF-α gene polymorphisms: association with disease susceptibility and response to anti-TNF-α treatment in psoriatic arthritis. J Invest Dermatol. 2014;134:2503–2509. doi:10.1038/jid.2014.123.
- Lai R, Xian D, Xiong X, et al. Proanthocyanidins: novel treatment for psoriasis that reduces oxidative stress and modulates Th17 and Treg cells. Redox Rep. 2018;23:130–135. doi:10.1080/13510002.2018.1462027.
- Lin X, Huang T. Oxidative stress in psoriasis and potential therapeutic use of antioxidants. Free Radic Res. 2016;50:585–595. doi:10.3109/10715762.2016.1162301.
- Chiang HM, Chen HC, Wu CS, et al. Rhodiola plants: chemistry and biological activity. J Food Drug Anal. 2015;23:359–369. doi:10.1016/j.jfda.2015.04.007.
- Sies H. Oxidative stress: a concept in redox biology and medicine. Redox Biodoi:10.1016/j.redox.2015.01.002.
- Reczek CR, Chandel NS. ROS-dependent signal transduction. Curr Opin Cell Biol. 2015;33:8–13. doi:10.1016/j.ceb.2014.09.010.
- Harrison DG. Basic science: pathophysiology: oxidative stress. J Am Soc Hypertens. 2014;8:601–603. doi:10.1016/j.jash.2014.07.002.
- Péter I, Jagicza A, Ajtay Z, et al. Psoriasis and oxidative stress. Orv Hetil. 2016;157:1781–1785. doi:10.1556/650.2016.30589.
- Gabr SA, Al-Ghadir AH. Role of cellular oxidative stress and cytochrome c in the pathogenesis of psoriasis. Arch Dermatol Res. 2012;304:451–457. doi:10.1007/s00403-012-1230-8.
- Barygina VV, Becatti M, Soldi G, et al. Altered redox status in the blood of psoriatic patients: involvement of NADPH oxidase and role of anti-TNF-α therapy. Redox Rep. 2013;18:100–106. doi:10.1179/1351000213Y.0000000045.
- Becatti M, Barygina V, Mannucci A, et al. Sirt1 protects against oxidative stress-induced apoptosis in fibroblasts from psoriatic patients: a new insight into the pathogenetic mechanisms of psoriasis. Int J Mol Sci. 2018;19. doi:10.3390/ijms19061572.
- Houshang N, Reza K, Masoud S, et al. Antioxidant status in patients with psoriasis. Cell Biochem Funct. 2014;32:268–273. doi: 10.1002/cbf.3011
- Lei Y, Wang K, Deng L, et al. Redox regulation of inflammation: old elements, a new story. Med Res Rev. 2015;35:306–340. doi:10.1002/med.21330.
- Georgescu SR, Tampa M, Caruntu C, et al. Advances in understanding the immunological pathways in psoriasis. Int J Mol Sci. 2019;20:739.doi:10.3390/ijms20030739.
- Richarz NA, Boada A, Carrascosa JM. Angiogenesis in dermatology - insights of molecular mechanisms and latest developments. Actas Dermosifiliogr. 2017;108:515–523. doi:10.1016/j.ad.2016.12.001.
- Numasaki M, Watanabe M, Suzuki T, et al. IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J Immunol. 2005;175:6177–6189. doi: 10.4049/jimmunol.175.9.6177
- Murdaca G, Spanò F, Cagnati P. Free radicals and endothelial dysfunction: potential positive effects of TNF-α inhibitors. Redox Rep. 2013;18:95–99. doi:10.1179/1351000213Y.0000000046.
- Murdaca G, Colombo BM, Cagnati P, et al. Endothelial dysfunction in rheumatic autoimmune diseases. Atherosclerosis. 2012;224:309–317. doi:10.1016/j.atherosclerosis.2012.05.013.
- Garcia-Peterson LM, Wilking-Busch MJ, Ndiaye MA, et al. Sirtuins in skin and skin cancers. Skin Pharmacol Physiol. 2017;30:216–224. doi:10.1159/000477417.
- Serravallo M, Jagdeo J, Glick SA, et al. Sirtuins in dermatology: applications for future research and therapeutics. Arch Dermatol Res. 2013;305:269–282. doi:10.1007/s00403-013-1320-2.
- Vachharajani VT, Liu T, Wang X, et al. Sirtuins link inflammation and metabolism. J Immunol Res. 2016;2016:1–10. doi:10.1155/2016/8167273.
- Zhou M, Luo J. Role of sirtuin 1 in the pathogenesis of ocular disease (review). Int J Mol Med. 2018;42:13–20. doi:10.3892/ijmm.2018.3623.
- Singh CK, Chhabra G, Ndiaye MA, et al. The role of sirtuins in antioxidant and redox signaling. Antioxid Redox Signal. 2018;28:643–661. doi:10.1089/ars.2017.7290.
- Blander G, Bhimavarapu A, Mammone T, et al. SIRT1 promotes differentiation of normal human keratinocytes. J Invest Dermatol. 2009;129:41–49. doi:10.1038/jid.2008.179.
- Wu Z, Uchi H, Morino-Koga S, et al. Resveratrol inhibition of human keratinocyte proliferation via SIRT1/ARNT/ERK dependent downregulation of aquaporin 3. J Dermatol Sci. 2014;75:16–23. doi:10.1016/j.jdermsci.2014.03.004.
- Wang Y, Huo J, Zhang D, et al. Chemerin/ChemR23 axis triggers an inflammatory response in keratinocytes through ROS-sirt1-NF-κB signaling. J Cell Biochem. 2019;120:6459–6470. doi:10.1002/jcb.27936.
- Fan X, Yan K, Meng Q, et al. Abnormal expression of SIRTs in psoriasis: decreased expression of SIRT 1-5 and increased expression of SIRT 6 and 7. Int J Mol Med. 2019;44:157–171. doi:10.3892/ijmm.2019.4173.
- Yan T, Huang J, Nisar MF, et al. The beneficial roles of SIRT1 in drug-induced liver injury. Oxid Med Cell Longev. 2019;2019:8506195. doi:10.1155/2019/8506195.
- Kyriakis JM, Kyriakis JM. Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. Physiol Rev. 2012;92:689–737. doi:10.1152/physrev.00028.2011.
- Corsini E, Galbiati V, Nikitovic D, et al. Role of oxidative stress in chemical allergens induced skin cells activation. Food Chem Toxicol. 2013;61:74–81. doi:10.1016/j.fct.2013.02.038.
- Koren Carmi I, Haj R, Yehuda H, et al. The role of oxidation in FSL-1 induced signaling pathways of an atopic dermatitis model in HaCaT keratinocytes. Adv Exp Med Biol. 2015;849:1–10. doi:10.1007/5584_2014_98.
- Bak DH, Lee E, Lee BC, et al. Therapeutic potential of topically administered γ-AlOOH on 2,4-dinitrochlorobenzene-induced atopic dermatitis-like lesions in Balb/c mice. Exp Dermatol. 2019;28:169–176. doi:10.1111/exd.13865.
- Koçtürk S, Yüksel Egrilmez M, Aktan Ş, et al. Melatonin attenuates the detrimental effects of UVA-irradiation in human dermal fibroblasts by suppressing oxidative damage and MAPK/AP-1 signal pathway in vitro. Photodermatol Photoimmunol Photomed. 2019. doi:10.1111/phpp.12456.
- Yu XJ, Li CY, Dai HY, et al. Expression and localization of the activated mitogen-activated protein kinase in lesional psoriatic skin. Exp Mol Pathol. 2007;83:413–418. doi:10.1016/j.yexmp.2007.05.002.
- Johansen C, Kragballe K, Westergaard M, et al. The mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin. Br J Dermatol. 2005;152:37–42. doi:10.1111/j.1365-2133.2004.06304.x.
- Takahashi H, Ibe M, Nakamura S, et al. Extracellular regulated kinase and c-Jun N-terminal kinase are activated in psoriatic involved epidermis. J. Dermatol. Sci. 2002;30:94–99. doi: 10.1016/S0923-1811(02)00064-6
- Schumacher M, Schuster C, Rogon ZM, et al. Efficient keratinocyte differentiation strictly depends on JNK-induced soluble factors in fibroblasts. J Invest Dermatol. 2014;134:1332–1341. doi:10.1038/jid.2013.535.
- Yang B, Xu B, Zhao H, et al. Dioscin protects against coronary heart disease by reducing oxidative stress and inflammation via Sirt1/Nrf2 and p38 MAPK pathways. Mol Med Rep. 2018;18:973–980. doi:10.3892/mmr.2018.9024.
- Gu X, Cai Z, Cai M, et al. AMPK/SIRT1/p38 MAPK signaling pathway regulates alcohol-induced neurodegeneration by resveratrol. Mol Med Rep. 2018;17:5402–5408. doi:10.3892/mmr.2018.8482.
- Wang T, Takikawa Y. Carnosic acid protects normal mouse hepatocytes against H2 O2 -induced cytotoxicity via sirtuin 1-mediated signaling. Hepatol Res. 2016;46:239–246. doi:10.1111/hepr.12563.
- Krueger JG, Suárez-Fariñas M, Cueto I, et al. A randomized, placebo-controlled study of SRT2104, a SIRT1 activator, in patients with moderate to severe psoriasis. PLoS One. 2015;10:e0142081. doi:10.1371/journal.pone.0142081.
- Nguyen TT, Ung TT, Li S, et al. Metformin inhibits lithocholic acid-induced interleukin 8 upregulation in colorectal cancer cells by suppressing ROS production and NF-kB activity. Sci Rep. 2019;9:2003. doi:10.1038/s41598-019-38778-2.
- Goldminz AM, Au SC, Kim N, et al. NF-κB: an essential transcription factor in psoriasis. J Dermatol Sci. 2013;69:89–94. doi:10.1016/j.jdermsci.2012.11.002.
- Hara-Chikuma M, Satooka H, Watanabe S, et al. Aquaporin-3-mediated hydrogen peroxide transport is required for NF-κB signalling in keratinocytes and development of psoriasis. Nat Commun. 2015;6:7454. doi:10.1038/ncomms8454.
- Abdou AG, Hanout HM. Evaluation of survivin and NF-kappaB in psoriasis, an immunohistochemical study. J Cutan Pathol. 2008;35:445–451. doi:10.1111/j.1600-0560.2007.00841.x.
- Yang H, Zhang W, Pan H, et al. SIRT1 activators suppress inflammatory responses through promotion of p65 deacetylation and inhibition of NF-κB activity. PLoS One. 2012;7:e46364. doi:10.1371/journal.pone.0046364.
- Kauppinen A, Suuronen T, Ojala J, et al. Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders. Cell Signal. 2013;25:1939–1948. doi:10.1016/j.cellsig.2013.06.007.
- Sano S, Chan KS, DiGiovanni J. Impact of Stat3 activation upon skin biology: a dichotomy of its role between homeostasis and diseases. J Dermatol Sci. 2008;50:1–14. doi:10.1016/j.jdermsci.2007.05.016.
- Zhou Q, Mrowietz U, Rostami-Yazdi M. Oxidative stress in the pathogenesis of psoriasis. Free Radic Biol Med. 2009;47:891–905. doi:10.1016/j.freeradbiomed.2009.06.033.
- Aggarwal BB, Kunnumakkara AB, Harikumar KB, et al. Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship? Ann N Y Acad Sci. 2009;1171:59–76. doi:10.1111/j.1749-6632.2009.04911.x.
- Calautti E, Avalle L. Psoriasis: A STAT3-Centric View. Int J Mol Sci. 2018: 19. doi:10.3390/ijms19010171.
- Zhang B, Xie S, Su Z, et al. Heme oxygenase-1 induction attenuates imiquimod-induced psoriasiform inflammation by negative regulation of Stat3 signaling. Sci Rep. 2016;6:21132. doi:10.1038/srep21132.
- Sestito R, Madonna S, Scarponi C, et al. STAT3-dependent effects of IL-22 in human keratinocytes are counterregulated by sirtuin 1 through a direct inhibition of STAT3 acetylation. FASEB J. 2011;25:916–927. doi:10.1096/fj.10-172288.
- Xie S, Su Z, Zhang B, et al. SIRT1 activation ameliorates aldara-induced psoriasiform phenotype and histology in mice. J Invest Dermatol. 2015;135:1915–1918. doi:10.1038/jid.2015.82.
- Bovenschen HJ, Langewouters AM, van de Kerkhof PCM. Dimethylfumarate for psoriasis: Pronounced effects on lesional T-cell subsets, epidermal proliferation and differentiation, but not on natural killer T cells in immunohistochemical study. Am J Clin Dermatol. 2010;11:343–350. doi:10.2165/11533240-000000000-00000.
- Antiga E, Bonciolini V, Volpi W, et al. Oral curcumin (meriva) is effective as an adjuvant treatment and is able to reduce IL-22 serum levels in patients with psoriasis vulgaris. Biomed Res Int. 2015;2015:1–7. doi:10.1155/2015/283634.
- Gnanaraj P, Dayalan H, Elango T, et al. Downregulation of involucrin in psoriatic lesions following therapy with propylthiouracil, an anti-thyroid thioureylene: immunohistochemistry and gene expression analysis. Int J Dermatol. 2015;54:302–306. doi:10.1111/ijd.12565.
- Visvanathan S, Baum P, Vinisko R, et al. Psoriatic skin molecular and histopathologic profiles after treatment with risankizumab versus ustekinumab. J Allergy Clin Immunol. 2018. doi:10.1016/j.jaci.2018.11.042.
- Ortiz Salvador JM, Saneleuterio Temporal M, Magdaleno Tapial J, et al. A prospective multi-center study assessing effectiveness and safety of secukinumab in a real-life setting in 158 patients. J Am Acad Dermatol. 2019. doi:10.1016/j.jaad.2019.02.062.
- Zhuang W, Yue L, Dang X, et al. Rosenroot (Rhodiola): potential applications in aging-related diseases. Aging Dis. 2019;10:134–146. doi:10.14336/AD.2018.0511.
- Su Y, Zong S, Wei C, et al. Salidroside promotes rat spinal cord injury recovery by inhibiting inflammatory cytokine expression and NF-κB and MAPK signaling pathways. J Cell Physiol. 2019;234:14259–14269. doi:10.1002/jcp.28124.
- Kong YH. Salidroside prevents skin carcinogenesis induced by DMBA/TPA in a mouse model through suppression of inflammation and promotion of apoptosis. Oncol Rep. 2018;39:2513–2526. doi:10.3892/or.2018.6381.
- Fan XJ, Wang Y, Wang L, et al. Salidroside induces apoptosis and autophagy in human colorectal cancer cells through inhibition of PI3K/Akt/mTOR pathway. Oncol Rep. 2016;36:3559–3567. doi:10.3892/or.2016.5138.
- Yin Y, Liu D. Salidroside prevents hydroperoxide-induced oxidative stress and apoptosis in retinal pigment epithelium cells. Exp Ther Med. 2018;16:2363–2368. doi:10.3892/etm.2018.6494.
- Qi Z, Qi S, Ling L, et al. Salidroside attenuates inflammatory response via suppressing JAK2-STAT3 pathway activation and preventing STAT3 transfer into nucleus. Int Immunopharmacol. 2016;35:265–271. doi:10.1016/j.intimp.2016.04.004.
- Wang CY, Sun ZN, Wang MX, et al. SIRT1 mediates salidroside-elicited protective effects against MPP+-induced apoptosis and oxidative stress in SH-SY5Y cells: involvement in suppressing MAPK pathways. Cell Biol Int. 2018;42:84–94. doi:10.1002/cbin.10864.
- Si PP, Zhen JL, Cai YL, et al. Salidroside protects against kainic acid-induced status epilepticus via suppressing oxidative stress. Neurosci Lett. 2016;618:19–24. doi:10.1016/j.neulet.2016.02.056.
- Zhu Z, Li J, Zhang X. Salidroside protects against ox-LDL-induced endothelial injury by enhancing autophagy mediated by SIRT1-FoxO1 pathway. BMC Complement Altern Med. 2019;19:111. doi:10.1186/s12906-019-2526-4.
- Zhao D, Sun X, Lv S, et al. Salidroside attenuates oxidized low-density lipoprotein-induced endothelial cell injury via promotion of the AMPK/SIRT1 pathway. Int J Mol Med. 2019;43:2279–2290. doi:10.3892/ijmm.2019.4153.
- Xu N, Huang F, Jian C, et al. Neuroprotective effect of salidroside against central nervous system inflammation-induced cognitive deficits: A pivotal role of sirtuin 1-dependent Nrf-2/HO-1/NF-κB pathway. Phytother Res. 2019;33:1438–1447. doi:10.1002/ptr.6335.